Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/13/2008US20080279948 Treatment of Asthma and Copd Using Triple-Combination Therapy
11/13/2008US20080279942 Mixture with hydrophilic polymer, acid and fluidization agent; improved dissolving properties ; hypotensive agents
11/13/2008US20080279940 For treatment or prevention of chronic pain
11/13/2008US20080279938 Zaltoprofen-containing sustained release tablet and process for the preparation thereof
11/13/2008US20080279936 Hypotensive agents; cardiovascular disorders; antiischemic agents; brain disorders; headaches; kidney disease; sustained release
11/13/2008US20080279935 Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base
11/13/2008US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis
11/13/2008US20080279933 Flurbiprofen and muscle relaxant combinations
11/13/2008US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier
11/13/2008US20080279930 Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279927 Non-Pegylated Long-Circulating Liposomes
11/13/2008US20080279925 Method(s) of preventing, arresting, reversing and treatment of atherosclerosis
11/13/2008US20080279923 Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons
11/13/2008US20080279920 Compositions For Treating Respiratory Viral Infections and Their Use
11/13/2008US20080279917 Bisbenzamidines for the Treatment of Pneumonia
11/13/2008US20080279916 Liposome Preparation
11/13/2008US20080279915 Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen
11/13/2008US20080279914 Transdermal composition comprising piroxicam-inorganic material complex and patch system comprising the same
11/13/2008US20080279913 Reduces oxidative stresses of the eye; using iron chelate compound
11/13/2008US20080279912 Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders
11/13/2008US20080279909 Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
11/13/2008US20080279905 Low irritation; containing ethylene-vinyl alcohol fibers and a crystal structure thermp[lastic resin
11/13/2008US20080279900 Gel useful for the delivery of cosmetic active ingredients
11/13/2008US20080279897 Method of Treating Cellular Damage
11/13/2008US20080279893 Lawsonia intracellularis immunological proteins
11/13/2008US20080279882 Phyto-nutraceutical synergistic composition for hyperlipedemic condition
11/13/2008US20080279870 ALK protein tyrosine kinase, cells and methods embodying and using same
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279867 Prevent trabsplant rejection; autoimmune diseases
11/13/2008US20080279866 Treating lymphomas, allergies and autoimmune diseases via apoptotic induction; using ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933) and lymphocyte specific immunoglobulins
11/13/2008US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics
11/13/2008US20080279860 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of metastatic ovarian cancer; immunotherapy
11/13/2008US20080279857 Therapeutic Agent
11/13/2008US20080279855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions
11/13/2008US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
11/13/2008US20080279846 lipoprotein-associated phospholipase A2 (Lp-PLA2)
11/13/2008US20080279845 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008US20080279844 Methods for Treating Cancer Targeting Transglutaminase
11/13/2008US20080279843 Using concentration of inflammation marker protein as evaluative signal for enzyme inhibitor dispension; drug delivery and antidiabetic agents
11/13/2008US20080279838 Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates
11/13/2008US20080279837 Composition for maintaining androgen and androgen-like uptake potential by cells
11/13/2008US20080279828 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008US20080279821 Arylpiperidinyl and arylpyrrolidinyl macrocyclic hepatitis c serine protease inhibitors
11/13/2008US20080279820 Compositions and Methods for Treating Burns
11/13/2008US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis
11/13/2008US20080279817 Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
11/13/2008US20080279815 Method for developing testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
11/13/2008US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders
11/13/2008US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation
11/13/2008US20080279808 2,3,4,5-Tetrahydroxy-6-Sulfooxy Hexanoic Acid, Pharmaceutically Acceptable Salts and Equilibrium Forms Thereof, Processes for Their Preparation, Pharmaceutical Compositions Comprising Such Compounds and Their Medical Use
11/13/2008US20080279807 Biodegradable Phosphoester Polyamines
11/13/2008US20080279797 film, which is non-transferable, long-lasting with a comfortable feeling of use to consumers over long periods of wear time; makeup kit
11/13/2008US20080279795 Tertiary Amine Functional Complex Polyester Polymers And Methods Of Production And Use
11/13/2008US20080279789 Synergistic mixture; prophylaxis and treatment of respiratory system disorders
11/13/2008US20080279786 Method for Extending Lifespan Delaying the Onset of Age-Related Disease
11/13/2008US20080279785 Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
11/13/2008US20080279784 Nasal administration of benzodiazepines
11/13/2008US20080279782 Polymers conjugated with platinum drugs
11/13/2008US20080279781 Glycosylated Carboranylporphyrins and Uses Thereof
11/13/2008US20080279776 Photosensitizers and MRI Enhancers
11/13/2008US20080279775 Benztropinamine Analogs as Dopamine Uptake Inhibitors
11/13/2008US20080279769 Enzyme Inhibitor Imaging Agents
11/13/2008US20080279766 analyzing a sample from a subject for the presence of a distinguishable agent such as cholate and applying information obtained from analyzing the presence of the distinguishable agent to determine a treatment
11/13/2008US20080279764 Method and composition for treating cancer
11/13/2008US20080276935 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
11/13/2008DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use
11/13/2008DE112005003752T5 Neues Pyrrolo[2,1-c][1,4]benzodiapezinhybrid und ein Verfahren zu dessen Herstellung New pyrrolo [2,1-c] [1,4] benzodiapezinhybrid and a process for its preparation
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008DE102008000872A1 New pyrazine compounds useful in the fungicidal agent, for combating plant pathogenic fungus in protecting materials, plants, ground or seeds and to treat cancer
11/13/2008DE102007022007A1 Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes Neuartike pharmaceuticals, to processes for their preparation and their use in the prophylaxis and treatment of CNS disorders and diabetes
11/13/2008DE102007021862A1 Wässrige pharmazeutische Zubereitung Aqueous pharmaceutical preparation
11/13/2008DE102007021549A1 Transdermales therapeutisches System enthaltend mindestens zwei Opioide Transdermal therapeutic system containing at least two opioids
11/13/2008DE102007019417A1 Tapentadol zur Schmerzbehandlung bei Arthrose Tapentadol for pain management in osteoarthritis
11/13/2008CA2809739A1 Morphinan compounds
11/13/2008CA2753209A1 Honokiol analogs and their use in treating cancers
11/13/2008CA2727939A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008CA2723470A1 Nasal administration of benzodiazepines
11/13/2008CA2703018A1 Methods of treating fungal infections
11/13/2008CA2694381A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2688584A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008CA2688319A1 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists
11/13/2008CA2688317A1 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations
11/13/2008CA2688187A1 Method of treament using fused aromatic compounds having anti-diabetic activity
11/13/2008CA2687107A1 Branched-chain amino acid composition for improving skeletal muscle protein metabolism
11/13/2008CA2686736A1 Methods and compositions for treating pulmonary hypertension
11/13/2008CA2686723A1 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
11/13/2008CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008CA2686638A1 Tnf.alpha. gene expression as a biomarker of sensitivity to antagonists of inhibitor of apoptosis proteins
11/13/2008CA2686589A1 Gamma secretase modulators
11/13/2008CA2686457A1 Novel polymorphic forms
11/13/2008CA2686419A1 Composition having lipolytic activity, production method thereof and use of the composition
11/13/2008CA2686414A1 Compositions and methods for treating disorders associated with salt or fluid retention
11/13/2008CA2686396A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
11/13/2008CA2686387A1 1, 3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
11/13/2008CA2686383A1 Natural bioactive compounds
11/13/2008CA2686382A1 Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
11/13/2008CA2686379A1 Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
1 ... 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 ... 7860